Insider Transactions in Q1 2025 at Roivant Sciences Ltd. (ROIV)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 28
2025
|
Richard Pulik CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,896
-0.7%
|
$20,856
$11.15 P/Share
|
|
Jan 23
2025
|
Ilan Oren |
SELL
Payment of exercise price or tax liability
|
Direct |
313
-0.31%
|
$3,443
$11.21 P/Share
|
|
Jan 23
2025
|
Ilan Oren |
BUY
Grant, award, or other acquisition
|
Direct |
2,386
+2.32%
|
-
|
|
Jan 23
2025
|
James C Momtazee |
SELL
Payment of exercise price or tax liability
|
Direct |
306
-0.32%
|
$3,366
$11.21 P/Share
|
|
Jan 23
2025
|
James C Momtazee |
BUY
Grant, award, or other acquisition
|
Direct |
1,248
+1.3%
|
-
|
|
Jan 23
2025
|
Epperly Melissa B, |
SELL
Payment of exercise price or tax liability
|
Direct |
180
-0.45%
|
$1,980
$11.21 P/Share
|
|
Jan 23
2025
|
Epperly Melissa B, |
BUY
Grant, award, or other acquisition
|
Direct |
1,672
+4.04%
|
-
|
|
Jan 23
2025
|
Vivek Ramaswamy > 10% Shareholder |
BUY
Bona fide gift
|
Indirect |
13,357,857
+50.0%
|
-
|
|
Jan 23
2025
|
Vivek Ramaswamy > 10% Shareholder |
SELL
Bona fide gift
|
Direct |
13,357,857
-25.0%
|
-
|
|
Jan 21
2025
|
Eric Venker President & COO |
SELL
Open market or private sale
|
Direct |
100,000
-12.02%
|
$1,100,000
$11.28 P/Share
|
|
Jan 21
2025
|
Eric Venker President & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+10.73%
|
$300,000
$3.85 P/Share
|
|
Jan 20
2025
|
Matthew Gline CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,623
-0.07%
|
$127,853
$11.15 P/Share
|
|
Jan 20
2025
|
Eric Venker President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,682
-1.17%
|
$95,502
$11.15 P/Share
|
|
Jan 20
2025
|
Rakhi Kumar Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,057
-0.52%
|
$11,627
$11.15 P/Share
|